Immortalization/NN
of/IN
CD4(+)/JJ
and/CC
CD8(+)/JJ
T/NN
lymphocytes/NNS
by/IN
human/JJ
T-cell/NN
leukemia/NN
virus/NN
type/NN
1/CD
Tax/NN
mutants/NNS
expressed/VBN
in/IN
a/DT
functional/JJ
molecular/JJ
clone/NN
./.

The/DT
human/JJ
T-cell/NN
leukemia/NN
virus/NN
type/NN
1/CD
(/(
HTLV-1/NN
)/)
transcriptional/JJ
trans-activator/NN
Tax/NN
has/VBZ
been/VBN
demonstrated/VBN
to/TO
have/VB
transforming/VBG
activity/NN
in/IN
multiple/JJ
cell/NN
culture/NN
and/CC
transgenic-mouse/JJ
models/NNS
./.
=====
In/IN
addition/NN
to/TO
activating/VBG
transcription/NN
from/IN
the/DT
viral/JJ
long/JJ
terminal/JJ
repeat/NN
(/(
LTR/NN
)/)
through/IN
the/DT
cyclic/JJ
AMP/NN
response/NN
element/NN
binding/NN
protein/activating/VBG|NN
transcription/NN
factor/NN
(/(
CREB/ATF/NN
)/)
family/NN
of/IN
transcription/NN
factors/NNS
,/,
Tax/NN
activates/VBZ
the/DT
expression/NN
of/IN
multiple/JJ
cellular/JJ
promoters/NNS
through/IN
the/DT
NF-kappaB/NN
pathway/NN
of/IN
transcriptional/JJ
activation/NN
./.
=====
The/DT
Tax/NN
mutants/NNS
M22/NN
and/CC
M47/NN
have/VBP
previously/RB
been/VBN
demonstrated/VBN
to/TO
selectively/RB
abrogate/VB
the/DT
ability/NN
of/IN
Tax/NN
to/TO
activate/VB
transcription/NN
through/IN
the/DT
NF-kappaB/NN
or/CC
CREB/ATF/NN
pathway/NN
,/,
respectively/RB
./.
=====
These/DT
mutations/NNS
were/VBD
introduced/VBN
in/IN
the/DT
tax/NN
gene/NN
of/IN
the/DT
ACH/NN
functional/JJ
molecular/JJ
clone/NN
of/IN
HTLV-1/NN
,/,
and/CC
virus/NN
produced/VBN
from/IN
the/DT
mutant/JJ
ACH/NN
clones/NNS
was/VBD
examined/VBN
for/IN
the/DT
ability/NN
to/TO
replicate/VB
and/CC
immortalize/VB
primary/JJ
human/JJ
lymphocytes/NNS
./.
=====
While/IN
virus/NN
derived/VBN
from/IN
the/DT
clone/NN
containing/VBG
the/DT
M47/NN
mutation/NN
retained/VBD
the/DT
ability/NN
to/TO
immortalize/VB
T/NN
lymphocytes/NNS
,/,
the/DT
M22/NN
mutant/NN
lost/VBD
the/DT
ability/NN
to/TO
immortalize/VB
infected/JJ
cells/NNS
./.
=====
These/DT
results/NNS
indicate/VBP
that/IN
activation/NN
of/IN
the/DT
CREB/ATF/NN
pathway/NN
by/IN
Tax/NN
is/VBZ
dispensable/JJ
for/IN
the/DT
immortalization/NN
of/IN
T/NN
cells/NNS
by/IN
HTLV-1/NN
,/,
whereas/IN
activation/NN
of/IN
the/DT
NF-kappaB/NN
pathway/NN
may/MD
be/VB
critical/JJ
./.